The 20 Best Basal Cell Skin Cancer Doctors Near Me in Canton, MI

Thomas Waldinger is a Dermatologist practicing medicine in Canton, Michigan. He has been practicing medicine for over 46 years. Dr. Waldinger is rated as an Experienced provider by MediFind in the treatment of Basal Cell Skin Cancer. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Cherry Angioma, Kaposiform Hemangioendothelioma, Hemangioendothelioma, and Tufted Angioma. Dr. Waldinger is board certified in American Board Of Dermatology. Dr. Waldinger is currently accepting new patients.

Arthur Gulick is a Dermatologist practicing medicine in Canton, Michigan. Dr. Gulick is rated as an Experienced provider by MediFind in the treatment of Basal Cell Skin Cancer. His clinical expertise encompasses Aseptic and Alopecic Nodules of Scalp (AANS), Plaque Psoriasis, Warts, and Actinic Keratosis.

Ann Lafond is a Dermatologist practicing medicine in Canton, Michigan. Dr. Lafond is rated as an Experienced provider by MediFind in the treatment of Basal Cell Skin Cancer. Her clinical expertise encompasses Hidradenitis Suppurativa, Calciphylaxis, Basal Cell Skin Cancer, and Granuloma Annulare.

David Blum is a Dermatologist practicing medicine in Canton, Michigan. Dr. Blum is rated as an Experienced provider by MediFind in the treatment of Basal Cell Skin Cancer. His clinical expertise encompasses Ecthyma, Warts, Localized Scleroderma, and Actinic Keratosis.

Dr. Christopher Bichakjian is professor of dermatology and chair of the Department of Dermatology at the University of Michigan Medical School.Dr. Bichakjian is a foremost expert in the field of cutaneous surgery and oncology. He has a special interest in Merkel cell carcinoma and established one of the first multidisciplinary programs in the world for this rare skin cancer in 2006. He has presented over 100 national and international invited lectures and visiting professorships, and authored or co-authored nearly 90 peer-reviewed publications with a primary focus on cutaneous oncology.Dr. Bichakjian received his medical degree from Radboud University in The Netherlands. After relocating to the US, he completed residency in dermatology and fellowship in micrographic surgery and cutaneous oncology at Michigan Medicine. He subsequently practiced Mohs surgery in private practice and served as adjunct faculty at Weill Medical College at Cornell University in New York City.In 2004, Dr. Bichakjian was recruited back to Ann Arbor to join the faculty in the Department of Dermatology at Michigan Medicine. He served as director of the UM Multidisciplinary Merkel Cell Carcinoma Program for more than a decade (2006-2017), In addition, he served as chief of the Division of Cutaneous Surgery and Oncology and as director of the Multidisciplinary Melanoma Program in the Rogel Cancer Center from 2017-2020. Dr. Bichakjian is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Merkel Cell Carcinoma, Basal Cell Skin Cancer, Melanoma, and Eccrine Porocarcinoma. Dr. Bichakjian is board certified in Dermatology and Micrographic Dermatologic Surgery.

Dr. Kelly Harms, MD, PhD, is a faculty member in the Department of Dermatology at the University of Michigan and the director of our Multi-disciplinary Cutaneous Oncology clinic. She provides patient care in our Cutaneous Surgery and Oncology clinical programs, including the Mohs surgery clinic and multidisciplinary melanoma and cutaneous oncology clinics located within the U-M Rogel Cancer Center. Dr. Harms is a board-certified dermatologist and ACGME Fellowship-trained Mohs Surgeon, with specialized training and expertise in treating high-risk skin cancer.Dr. Harms joined the Dermatology faculty in 2014, upon completing her ACGME procedural dermatology fellowship, with advanced training in melanoma and cutaneous surgery and oncology at the Rogel Cancer Center. Her clinical work is focused on Mohs surgery and associated reconstruction, as well as the complex management of patients seen within our Multidisciplinary Melanoma and Merkel Cell Programs.Dr. Harms received her medical degree from the University of Alabama School of Medicine and her Ph.D. degree from the Medical Scientist Training Program in the Department of Cell Biology at the University of Alabama at Birmingham. She completed her internship in the Department of Internal Medicine, University of Michigan Hospitals. She completed her dermatology residency, post-doctoral research training, and procedural dermatology fellowship in the Department of Dermatology, University of Michigan Medical School. Her clinical research is focused on skin cancer biology and epidemiology, and therapy. Dr. Harms is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Merkel Cell Carcinoma, Melanoma, Eccrine Porocarcinoma, and Basal Cell Skin Cancer. Dr. Harms is board certified in Dermatology and Micrographic Dermatologic Surgery.

In 2008, Dr. Dlugosz was named Poth Professor of Cutaneous Oncology in the Dermatology Department at the University of Michigan in Ann Arbor. He is Scientific Director of the Cutaneous Oncology Program of the University of Michigan Comprehensive Cancer Center. He received his M.D. at the Pennsylvania State University College of Medicine in 1984, did an internship at the Roger Williams General Hospital in Providence, RI, and completed his dermatology residency, including a year as Chief Resident, at the University of Pennsylvania in Philadelphia, in 1988. He received his post-doctoral training with Dr. Stuart Yuspa at the National Cancer Institute, where he subsequently established an independent research program prior to his recruitment to the University of Michigan in 1997.Dr. Dlugosz has received multiple awards, grants, and fellowships from the National Institutes of Health, American Cancer Society, American Association for Cancer Research, Society for Investigative Dermatology, and Dermatology Foundation. He was elected to the American Society for Clinical Investigation in 2002, has been included in the Best Doctors in America listing since 2003, and was elected to the American Dermatological Association in 2005.The National Institutes of Health and other scientific agencies frequently enlist Dr. Dlugosz as a grant reviewer. He is also an ad hoc reviewer for multiple scholarly journals, and is frequently invited to speak, or chair sessions, at major scientific meetings both in the United States and abroad. Dr. Dlugosz is an author on over 60 published papers.Dr. Dlugosz's basic research program is centered on two interrelated areas. He is investigating how the abnormal regulation of an embryonic signaling pathway, called the Hedgehog pathway, causes tumor development in skin and several other organs. In other studies, he is investigating the role of the Hedgehog pathway in development, growth, and regeneration of hair follicles and related structures. Dr. Dlugosz is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. He is also highly rated in 88 other conditions, according to our data. His clinical expertise encompasses Cicatricial Pemphigoid, Pemphigus, Bullous Pemphigoid, and Pemphigus Vulgaris. Dr. Dlugosz is board certified in Dermatology.

Ali Berry is a Dermatologist and an Internal Medicine provider practicing medicine in Canton, Michigan. He has been practicing medicine for over 24 years. Dr. Berry is rated as an Experienced provider by MediFind in the treatment of Basal Cell Skin Cancer. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Warts, Actinic Keratosis, Neurocutaneous Melanosis, and Plaque Psoriasis. Dr. Berry is board certified in American Board Of Dermatology.

Andrea Schrieber is a Dermatologist practicing medicine in Canton, Michigan. She has been practicing medicine for over 20 years. Dr. Schrieber is rated as an Experienced provider by MediFind in the treatment of Basal Cell Skin Cancer. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Warts, Neurocutaneous Melanosis, Actinic Keratosis, and Giant Congenital Melanocytic Nevus. Dr. Schrieber is board certified in American Board Of Dermatology.

Timothy Johnson is a Dermatologist practicing medicine in Ann Arbor, Michigan. Dr. Johnson is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Melanoma, Squamous Cell Skin Carcinoma, Basal Cell Skin Cancer, and Merkel Cell Carcinoma.

Dr. Lowe received her undergraduate degree from Occidental College, Los Angeles, California in 1981 and her M.D. degree from the University of Texas Medical School at Houston, Houston, Texas in 1985. She did a transitional internship at St. Joseph's Hospital, Houston, Texas from 1985-1986 and then was a Post-doctoral Fellow in the Department of Dermatology at the University of Texas Medical School at Houston. From 1987-1989, she completed her residency training in dermatology at the University of Texas Medical School at Houston, followed by a Dermatopathology Fellowship at the University of Colorado School of Medicine, Denver, Colorado, from 1990-1991. Dr. Lowe is board certified in both Dermatology and Dermatopathology.In 1990, Dr. Lowe served as an Instructor in the Department of Dermatology at the University of Texas Medical School at Houston, Houston, Texas. She moved to the Department of Dermatology at Henry Ford Hospital, Detroit, Michigan, where she was a Senior Staff Physician and Director of Dermatopathology from 1991-1996. In 1996 she joined the faculty of the Departments of Pathology and Dermatology at the University of Michigan Medical School, Ann Arbor, Michigan, as Assistant Professor, where she was promoted to Associate Professor in 1998, and to Professor in 2004. She served as the Director of Dermatopathology in the Department of Pathology from 1996-2012.While at the University of Michigan Medical School, Dr. Lowe has been actively involved in the dermatopathology service, teaching and academic pursuits. She has been recognized institutionally and nationally as an educator and clinician. In 2013, Dr. Lowe received the Walter Nickel Teaching Award given by the American Society of Dermatopathology and also received the Outstanding Clinician of the Year Award bestowed by the University of Michigan Medical School. In 2015, she was inducted into the University of Michigan League of Clinical Excellence. Dr. Lowe received the William B. Taylor Resident Teaching Award from the Department of Dermatology, University of Michigan in 1999 and 2005 for exemplary teaching. She has been recognized annually since 2003 in America's Top Doctors for Cancer by Castle Connolly Medical Ltd. She has served on national committees, including the American Board of Dermatology, Dermatopathology Test Committee and the American Board of Pathology, Dermatopathology Test Committee and has served on the editorial boards of both the Journal of the American Academy of Dermatology and Cancer. Dr. Lowe is the author or co-author of more than 130 publications in peer-reviewed journals. Dr. Lowe is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Melanoma, Sebaceous Adenoma, Syringoma, and Syringocystadenoma Papilliferum. Dr. Lowe is board certified in Dermatology and Dermatopathology.

Aaron Cetner is a Dermatologist practicing medicine in Novi, Michigan. He has been practicing medicine for over 22 years. Dr. Cetner is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, Head and Neck Squamous Cell Carcinoma (HNSCC), and Bowen's Disease. Dr. Cetner is board certified in American Board Of Dermatology and American Board Of Dermatology. Dr. Cetner is currently accepting new patients.

Chelsea Luther is a Dermatologist practicing medicine in Canton, Michigan. She has been practicing medicine for over 10 years. Dr. Luther is rated as an Experienced provider by MediFind in the treatment of Basal Cell Skin Cancer. Her clinical expertise encompasses Rosacea, Actinic Keratosis, Warts, and Erythroderma. Dr. Luther is board certified in American Board Of Dermatology.

Alison Boucher is a Dermatologist practicing medicine in Plymouth, Michigan. Dr. Boucher is rated as an Experienced provider by MediFind in the treatment of Basal Cell Skin Cancer. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Actinic Keratosis, Mycosis Fungoides, Keloids, and Warts.

Megan Iacco is a Dermatologist practicing medicine in Plymouth, Michigan. Dr. Iacco is rated as an Experienced provider by MediFind in the treatment of Basal Cell Skin Cancer. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Rosacea, Epidermoid Cyst, Autosomal Recessive Hypotrichosis, and Alopecia Areata.

Sonam Rama is a Dermatologist practicing medicine in Plymouth, Michigan. Dr. Rama is rated as an Experienced provider by MediFind in the treatment of Basal Cell Skin Cancer. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Neurocutaneous Melanosis, Giant Congenital Nevus, Familial Atypical Multiple Mole Melanoma Syndrome, and Giant Congenital Melanocytic Nevus.

Francisca Kartono is a Dermatologist practicing medicine in Northville, Michigan. She has been practicing medicine for over 19 years. Dr. Kartono is rated as an Experienced provider by MediFind in the treatment of Basal Cell Skin Cancer. She is also highly rated in 58 other conditions, according to our data. Her clinical expertise encompasses Contact Dermatitis, Actinic Keratosis, Rosacea, and Warts. Dr. Kartono is board certified in American Osteopathic Board Of Dermatology. Dr. Kartono is currently accepting new patients.

Dr. Maya Aravind is a board-certified dermatologist and Assistant Professor of Dermatology at the University of Michigan. She provides medical dermatology diagnosis and treatment to patients of all ages within in our medical dermatology outpatient clinics.Dr. Aravind received her medical degree from the University of Michigan Medical School, and her master of science degree in clinical research from the University of Michigan School of Public Health Rackham School of Graduate Studies. Following graduation, she completed her transitional year internship at Oakwood Hospital in Dearborn, MI, and her dermatology residency at the U-M Department of Dermatology. Dr. Aravind practiced dermatology in Tennessee and Texas before joining the clinical faculty of the University of Michigan Department of Dermatology in 2022. Dr. Aravind is rated as an Advanced provider by MediFind in the treatment of Basal Cell Skin Cancer. She is also highly rated in 38 other conditions, according to our data. Her clinical expertise encompasses Actinic Keratosis, Melanoma, Warts, and Seborrheic Keratosis.

Dr. May Chan obtained her medical degree from the State University of New York at Buffalo and was a Howard Hughes Research Scholar in 2005-2006. She completed residency training in Anatomic Pathology at Beth Israel Deaconess Medical Center in Boston, followed by a Dermatopathology fellowship at Harvard. She joined the University of Michigan in 2011 and is now a Professor of Pathology and Dermatology. She is the Interim Section Head for Dermatopathology, the Program Director for the Dermatopathology Fellowship, and the Medical Director of the Immunohistochemistry Laboratory. She also serves on the Test Development and Advisory Committee of the American Board of Pathology.Dr. Chan is an editorial board member of Modern Pathology and Journal of Cutaneous Pathology. She has a broad research interest in the areas of inflammatory skin diseases, melanocytic lesions, cutaneous adnexal neoplasms, and immunohistochemistry. She is the author/co-author of over 90 peer-reviewed publications and the book, Handbook of Direct Immunofluorescence: A Pattern-based Approach to Skin and Mucosal Biopsies.Dr. Chan is board certified in Anatomic Pathology and Dermatopathology. In addition to her primary role as a dermatopathologist, Dr. Chan retains her interest in surgical pathology including interpretation of head and neck, soft tissue, pulmonary, and endocrine cases, as well as intraoperative frozen sections. Over the years she has been invited to speak at national and international meetings hosted by the United States and Canadian Academy of Pathology (USCAP), the American Society of Dermatopathology (ASDP), the College of American Pathologists (CAP), the American Society for Clinical Pathology (ASCP), the American Academy of Dermatology (AAD), the European Nail Society, and Dermpedia. Dr. Chan is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Melanoma, Basal Cell Skin Cancer, Sebaceous Adenoma, and Squamous Cell Skin Carcinoma.

After receiving my M.D. and Ph.D. at the University of Alabama at Birmingham, I came to the University of Michigan for residency training in Anatomic Pathology. During my residency and subsequent Dermatopathology fellowship, I became interested in mechanistic studies of cutaneous and soft-tissue malignancies. Upon completion of my fellowship in June 2012, I accepted a faculty position at UMHS with joint appointments in the Departments of Dermatology and Pathology, in which I continue to investigate molecular events in the pathogenesis of Merkel cell carcinoma and other cutaneous malignancies, while maintaining clinical effort in dermatopathology and molecular dermatopathology. Dr. Harms is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Merkel Cell Carcinoma, Tieche-Jadassohn Nevus, Melanoma, and Sebaceous Adenoma. Dr. Harms is board certified in Pathology-Anatomic and Dermatopathology.